下颌定位器引导的定制下颌前移治疗对阻塞性睡眠呼吸暂停的预测价值
这项前瞻性多中心队列研究纳入77例OSA患者,经DISE联合下颌可调定位器(SAM)评估后,66例按SAM推荐接受MAD治疗。MAD治疗后AHI从32.26降至7.19,最低血氧饱和度从80.83%升至85.87%,CT90从11.33%降至3.99%,DISE-SAM方案显示出较高的阳性预测价值。
要点
- DISE联合SAM定位器可稳定模拟MAD效果,辅助筛选适合MAD治疗的OSA患者。
- 按SAM推荐接受MAD治疗者,AHI、最低血氧饱和度和CT90均显著改善。
- DISE-SAM方案在定制成功标准下仍显示较高阳性预测价值。
核心结论
- DISE-SAM方案在所选MAD治疗患者中显示出较高的阳性预测价值,并显著改善关键呼吸参数。
研究设计与样本
- 前瞻性多中心队列研究,纳入3家医院的77例OSA患者,其中66例根据SAM推荐完成MAD治疗。
主要发现
- MAD治疗后AHI从32.26降至7.19,最低血氧饱和度从80.83%升至85.87%,CT90从11.33%降至3.99%。
- 分层分析显示中度和重度OSA组以及各SAM推荐类别均有显著治疗效果。
- 使用定制成功标准时,DISE-SAM方案仍显示较高阳性预测价值。
关键数值与推荐
- SAM推荐分为单用(S)、替代(A)或多重治疗策略(M)三类。
- 疗效分析采用基于AHI-血氧饱和度的标准成功标准及按SAM推荐类别新定制的标准。
临床怎么用
- 对OSA患者行DISE联合SAM定位器评估,可辅助筛选MAD治疗获益人群并指导治疗策略选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Mandibular advancement devices (MADs) are a recognized alternative to continuous positive airway pressure (CPAP) for treating obstructive sleep apnea (OSA), though patient selection is still challenging. Tailored MAD guided through drug induced sleep endoscopy (DISE) with a mandibular titratable positioner (SAM) offers a stable and reproducible simulation of MAD effects during DISE, potentially enhancing outcomes after this DISE-SAM protocol. We aim to assess its positive predictive value (PPV) in patients treated with MAD by analyzing changes in AHI, minimum oxygen saturation, and CT90, considering OSA severity and recommendations based on the expected response. STUDY DESIGN: Prospective cohort study. SETTING: Academic secondary medical centers. METHODS: A prospective, multicenter study was conducted including 77 OSA patients across 3 hospitals. After DISE with the SAM device, 66 patients concluded MAD therapy based on SAM recommendations: Single use (S), Alternative (A), or Multiple treatment approach (M). Pretreatment and posttreatment sleep studies measured AHI, Min O2 Sat, and CT90. Response was analyzed with standard AHI-oxygen saturation-based criteria and newly tailored criteria per SAM recommendation category. RESULTS: MAD therapy led to significant improvement in AHI (from 32.26 to 7.19), min O2 Sat (from 80.83% to 85.87%), and CT90 (from 11.33% to 3.99%). Stratified analyses showed significant treatment effects in moderate and severe OSA groups and across SAM recommendations. The MAD therapy guided through DISE-SAM protocol demonstrated high PPV, also when using tailored success criteria. CONCLUSIONS: The DISE-SAM protocol demonstrated a high positive predictive value and significant improvements in key respiratory parameters among the selected patients using MAD.
引用
- Fernández-Sanjuán P, Bosco G, Pérez-Martín N, et al. Tailored Mandibular Advancement Therapy Guided Through a Mandibular Positioner: Predictive Value in Obstructive Sleep Apnea. Otolaryngol Head Neck Surg. 2026. PMID: 42549506. doi:10.1002/ohn.70356
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。